1. Home
  2. CNSP vs DTSS Comparison

CNSP vs DTSS Comparison

Compare CNSP & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

HOLD

Current Price

$5.22

Market Cap

8.5M

Sector

Health Care

ML Signal

HOLD

Logo Datasea Inc.

DTSS

Datasea Inc.

HOLD

Current Price

$0.94

Market Cap

7.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNSP
DTSS
Founded
2017
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.5M
7.4M
IPO Year
2019
2026

Fundamental Metrics

Financial Performance
Metric
CNSP
DTSS
Price
$5.22
$0.94
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$20.00
N/A
AVG Volume (30 Days)
5.7K
6.1M
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
8.03
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.90
$0.53
52 Week High
$10.59
$2.50

Technical Indicators

Market Signals
Indicator
CNSP
DTSS
Relative Strength Index (RSI) 42.31 59.05
Support Level $5.15 $0.73
Resistance Level $5.53 $0.94
Average True Range (ATR) 0.17 0.17
MACD -0.10 0.04
Stochastic Oscillator 17.56 23.29

Price Performance

Historical Comparison
CNSP
DTSS

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

About DTSS Datasea Inc.

Datasea Intelligent Technology Ltd, formerly known as Datasea Inc, is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).

Share on Social Networks: